You are here

  • Home
  • Archive
  • Volume 82, Issue 4
  • Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

Article metrics

Article menu

This article has a correction. Please see:

Spondyloarthritis
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials

 

Online download statistics by month:

Online download statistics by month: January 2023 to September 2024

AbstractFullPdf
Jan 202315791567610
Feb 202310531001505
Mar 202314231409564
Apr 2023884860390
May 2023755744308
Jun 2023855853287
Jul 2023561540232
Aug 2023483473190
Sep 2023508496187
Oct 2023469443188
Nov 2023448438239
Dec 2023455410233
Jan 2024484356245
Feb 2024384364224
Mar 2024488470293
Apr 2024509481267
May 2024419390215
Jun 2024443414190
Jul 2024404381229
Aug 2024402394202
Sep 2024400395206
Total13406128796004